Intuitive Surgical, Inc. Cost of Revenue
Intuitive Surgical, Inc. (ISRG) reported Cost of Revenue of $277.00 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-07-20.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2018-07-20
- Intuitive Surgical, Inc. cost of revenue for the quarter ending 2018-06-30 was $277.00M, a 21.12% increase year-over-year.
- Intuitive Surgical, Inc. cost of revenue for the quarter ending 2018-03-31 was $253.70M, a 20.92% increase year-over-year.
- Intuitive Surgical, Inc. cost of revenue for the quarter ending 2017-12-31 was $259.10M, a 12.80% increase year-over-year.
- Intuitive Surgical, Inc. cost of revenue for the quarter ending 2017-09-30 was $239.30M, a 22.15% increase year-over-year.
- Intuitive Surgical, Inc. cost of revenue for fiscal 2017 was $934.80M, a 14.80% increase from fiscal 2016.
- Intuitive Surgical, Inc. cost of revenue for fiscal 2016 was $814.30M, a 0.97% increase from fiscal 2015.
- Intuitive Surgical, Inc. cost of revenue for fiscal 2015 was $806.50M, a 12.34% increase from fiscal 2014.
- Intuitive Surgical, Inc. cost of revenue for fiscal 2014 was $717.90M, a 7.01% increase from fiscal 2013.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | $277.00M 10-Q · filed 2018-07-20 | $530.70M 10-Q · filed 2018-07-20 | $789.80M derived: sum of 3 quarters · filed 2018-07-20 | $1.03B derived: sum of 4 quarters · filed 2018-07-20 | ||||
| 2018-03-31 | $253.70M 10-Q · filed 2018-04-18 | $512.80M derived: sum of 2 quarters · filed 2018-04-18 | $752.10M derived: sum of 3 quarters · filed 2018-04-18 | $980.80M derived: sum of 4 quarters · filed 2018-07-20 | ||||
| 2017-12-31 | $259.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02 | $498.40M derived: sum of 2 quarters · filed 2018-02-02 | $727.10M derived: sum of 3 quarters · filed 2018-07-20 | $934.80M 10-K · filed 2018-02-02 | ||||
| 2017-09-30 | $239.30M 10-Q · filed 2017-10-20 | $468.00M derived: sum of 2 quarters · filed 2018-07-20 | $675.70M 10-Q · filed 2017-10-20 | $907.50M derived: sum of 4 quarters · filed 2018-07-20 | ||||
| 2017-06-30 | $228.70M 10-Q · filed 2018-07-20 | $228.30M 10-Q · filed 2017-07-21 | $438.50M 10-Q · filed 2018-07-20 | $436.40M 10-Q · filed 2017-07-21 | $668.20M derived: sum of 3 quarters · filed 2018-07-20 | $864.10M derived: sum of 4 quarters · filed 2018-07-20 | ||
| 2017-03-31 | $209.80M 10-Q · filed 2018-04-18 | $208.10M 10-Q · filed 2017-04-19 | $439.50M derived: sum of 2 quarters · filed 2018-04-18 | $635.40M derived: sum of 3 quarters · filed 2018-04-18 | $834.60M derived: sum of 4 quarters · filed 2018-04-18 | |||
| 2016-12-31 | $229.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02 | $425.60M derived: sum of 2 quarters · filed 2018-02-02 | $624.80M derived: sum of 3 quarters · filed 2018-02-02 | $814.30M 10-K · filed 2018-02-02 | ||||
| 2016-09-30 | $195.90M 10-Q · filed 2017-10-20 | $395.10M derived: sum of 2 quarters · filed 2017-10-20 | $584.60M 10-Q · filed 2017-10-20 | $802.30M derived: sum of 4 quarters · filed 2018-02-02 | ||||
| 2016-06-30 | $199.20M 10-Q · filed 2017-07-21 | $388.70M 10-Q · filed 2017-07-21 | $606.40M derived: sum of 3 quarters · filed 2018-02-02 | $800.30M derived: sum of 4 quarters · filed 2018-02-02 | ||||
| 2016-03-31 | $189.50M 10-Q · filed 2017-04-19 | $407.20M derived: sum of 2 quarters · filed 2018-02-02 | $601.10M derived: sum of 3 quarters · filed 2018-02-02 | $800.70M derived: sum of 4 quarters · filed 2018-02-02 | ||||
| 2015-12-31 | $217.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02 | $411.60M derived: sum of 2 quarters · filed 2018-02-02 | $611.20M derived: sum of 3 quarters · filed 2018-02-02 | $806.50M 10-K · filed 2018-02-02 | ||||
| 2015-09-30 | $193.90M 10-Q · filed 2016-10-19 | $393.50M derived: sum of 2 quarters · filed 2016-10-19 | $588.80M 10-Q · filed 2016-10-19 | $800.10M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2015-06-30 | $199.60M 10-Q · filed 2016-07-20 | $394.90M 10-Q · filed 2016-07-20 | $606.20M derived: sum of 3 quarters · filed 2017-02-06 | $795.70M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2015-03-31 | $195.30M 10-Q · filed 2016-04-19 | $406.60M derived: sum of 2 quarters · filed 2017-02-06 | $596.10M derived: sum of 3 quarters · filed 2017-02-06 | $763.90M derived: sum of 4 quarters · filed 2017-02-06 | ||||
| 2014-12-31 | $211.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06 | $400.80M derived: sum of 2 quarters · filed 2017-02-06 | $568.60M derived: sum of 3 quarters · filed 2017-02-06 | $717.90M 10-K · filed 2017-02-06 | ||||
| 2014-09-30 | $189.50M 10-Q · filed 2015-10-21 | $357.30M derived: sum of 2 quarters · filed 2015-10-21 | $506.60M 10-Q · filed 2015-10-21 | $684.80M derived: sum of 4 quarters · filed 2016-02-02 | ||||
| 2014-06-30 | $167.80M 10-Q · filed 2015-07-22 | $317.10M 10-Q · filed 2015-07-22 | $495.30M derived: sum of 3 quarters · filed 2016-02-02 | $637.60M derived: sum of 4 quarters · filed 2016-02-02 | ||||
| 2014-03-31 | $149.30M 10-Q · filed 2015-04-22 | $327.50M derived: sum of 2 quarters · filed 2016-02-02 | $469.80M derived: sum of 3 quarters · filed 2016-02-02 | $643.10M derived: sum of 4 quarters · filed 2016-02-02 | ||||
| 2013-12-31 | $178.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02 | $320.50M derived: sum of 2 quarters · filed 2016-02-02 | $493.80M derived: sum of 3 quarters · filed 2016-02-02 | $670.90M 10-K · filed 2016-02-02 | ||||
| 2013-09-30 | $142.30M 10-Q · filed 2014-10-23 | $315.60M derived: sum of 2 quarters · filed 2014-10-23 | $492.70M 10-Q · filed 2014-10-23 | $664.10M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2013-06-30 | $173.30M 10-Q · filed 2014-07-24 | $350.40M 10-Q · filed 2014-07-24 | $521.80M derived: sum of 3 quarters · filed 2015-02-06 | $669.50M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2013-03-31 | $177.10M 10-Q · filed 2014-04-25 | $348.50M derived: sum of 2 quarters · filed 2015-02-06 | $496.20M derived: sum of 3 quarters · filed 2015-02-06 | $646.30M derived: sum of 4 quarters · filed 2015-02-06 | ||||
| 2012-12-31 | $171.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $319.10M derived: sum of 2 quarters · filed 2015-02-06 | $469.20M derived: sum of 3 quarters · filed 2015-02-06 | $608.50M 10-K · filed 2015-02-06 | ||||
| 2012-09-30 | $147.70M 10-Q · filed 2013-10-18 | $297.80M derived: sum of 2 quarters · filed 2013-10-18 | $437.10M 10-Q · filed 2013-10-18 | $571.00M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2012-06-30 | $150.10M 10-Q · filed 2013-07-22 | $289.40M 10-Q · filed 2013-07-22 | $423.30M derived: sum of 3 quarters · filed 2014-02-03 | $544.50M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2012-03-31 | $139.30M 10-Q · filed 2013-04-19 | $273.20M derived: sum of 2 quarters · filed 2014-02-03 | $394.40M derived: sum of 3 quarters · filed 2014-02-03 | $513.50M derived: sum of 4 quarters · filed 2014-02-03 | ||||
| 2011-12-31 | $133.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03 | $255.10M derived: sum of 2 quarters · filed 2014-02-03 | $374.20M derived: sum of 3 quarters · filed 2014-02-03 | $483.50M 10-K · filed 2014-02-03 | ||||
| 2011-09-30 | $121.20M 10-Q · filed 2012-10-18 | $240.30M derived: sum of 2 quarters · filed 2012-10-18 | $349.60M 10-Q · filed 2012-10-18 | $456.80M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2011-06-30 | $119.10M 10-Q · filed 2012-07-23 | $228.40M 10-Q · filed 2012-07-23 | $335.60M derived: sum of 3 quarters · filed 2013-02-04 | $429.40M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2011-03-31 | $109.30M 10-Q · filed 2012-04-19 | $216.50M derived: sum of 2 quarters · filed 2013-02-04 | $310.30M derived: sum of 3 quarters · filed 2013-02-04 | $404.20M derived: sum of 4 quarters · filed 2013-02-04 | ||||
| 2010-12-31 | $107.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-04 | $201.00M derived: sum of 2 quarters · filed 2013-02-04 | $294.90M derived: sum of 3 quarters · filed 2013-02-04 | $383.00M 10-K · filed 2013-02-04 | ||||
| 2010-09-30 | $93.80M 10-Q · filed 2011-10-19 | $187.70M derived: sum of 2 quarters · filed 2011-10-19 | $275.80M 10-Q · filed 2011-10-19 | $365.70M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2010-06-30 | $93.90M 10-Q · filed 2011-07-20 | $182.00M 10-Q · filed 2011-07-20 | $271.90M derived: sum of 3 quarters · filed 2012-02-06 | $353.00M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2010-03-31 | $88.10M 10-Q · filed 2011-04-20 | $178.00M derived: sum of 2 quarters · filed 2012-02-06 | $259.10M derived: sum of 3 quarters · filed 2012-02-06 | $329.50M derived: sum of 4 quarters · filed 2012-02-06 | ||||
| 2009-12-31 | $89.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06 | $171.00M derived: sum of 2 quarters · filed 2012-02-06 | $241.40M derived: sum of 3 quarters · filed 2012-02-06 | $301.10M 10-K · filed 2012-02-06 | $301.12M 10-K · filed 2010-01-29 | |||
| 2009-09-30 | $81.10M 10-Q · filed 2010-10-20 | $81.13M 10-Q · filed 2009-10-21 | $151.50M derived: sum of 2 quarters · filed 2010-10-20 | $211.20M 10-Q · filed 2010-10-20 | $211.24M 10-Q · filed 2009-10-21 | $277.36M derived: sum of 4 quarters · filed 2011-02-01 | ||
| 2009-06-30 | $70.40M 10-Q · filed 2010-07-23 | $70.44M 10-Q · filed 2009-07-23 | $130.10M 10-Q · filed 2010-07-23 | $130.11M 10-Q · filed 2009-07-23 | $196.26M derived: sum of 3 quarters · filed 2011-02-01 | $262.68M derived: sum of 4 quarters · filed 2011-02-01 | ||
| 2009-03-31 | $59.70M 10-Q · filed 2010-04-20 | $125.86M derived: sum of 2 quarters · filed 2011-02-01 | $192.28M derived: sum of 3 quarters · filed 2011-02-01 | $255.41M derived: sum of 4 quarters · filed 2011-02-01 | ||||
| 2008-12-31 | $66.16M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-01 | $132.58M derived: sum of 2 quarters · filed 2011-02-01 | $195.71M derived: sum of 3 quarters · filed 2011-02-01 | $254.10M 10-K · filed 2011-02-01 | $254.14M 10-K · filed 2010-01-29 | |||
| 2008-09-30 | $66.42M 10-Q · filed 2009-10-21 | $129.55M derived: sum of 2 quarters · filed 2009-10-21 | $187.94M 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | $63.13M 10-Q · filed 2009-07-23 | $121.52M 10-Q · filed 2009-07-23 | ||||||
| 2007-12-31 | $186.54M 10-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |